Cortecs International receives 510(K) clearance from the FDA for Helisal Rapid Blood.

Business Wire › May 30, 1996

Linked as:

Extract

Cortecs International receives 510(K) clearance from the FDA for Helisal Rapid Blood.

LONDON--(BUSINESS WIRE)--May 30, 1996--Cortecs International (NASDAQ:DLVRY/ LSE:COR/ASX:CRI) today announced that it has received 510(k) clearance in the U.S. from the Food and Drug Administration (FDA) for its Helisal Rapid Blood diagnostic kit for the detec...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

U. S. Labor Department Acts to Improve Access of Hurricane Victims to 401(K) Loans and Withdrawals | Joint Statement by Governor Tim Pawlenty and Senator Norm Coleman | 'matador' dodges comedy, drama classification; adequate acting, poor editing mark the brosnan-kinnear ... | Myrtle G. Osmundson | sentencia nº 2607 de consiglio di stato may 16 2008 | Sentencia nº 5149 de Consiglio di Stato, September 30, 2008 | Sentencia nº 706 de Consiglio di Stato January 29 2008 | Sentencia nº 173 de Consiglio di Stato January 15 2008